Bcl-2 is an anti-apoptotic protein that is overexpressed in various lymphomas, and venetoclax promotes apoptosis of tumor cells by inhibiting Bcl-2, thereby exerting an anti-tumor effect. The gene discussed is BCL2; the disease is lymphoma.